BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9595892)

  • 1. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
    Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
    J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 3. Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
    Nagata T; Ono K; Nakayama K
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):434-6. PubMed ID: 17610670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine in anorexia nervosa.
    Lee S
    J Clin Psychiatry; 1991 May; 52(5):240-1. PubMed ID: 2033033
    [No Abstract]   [Full Text] [Related]  

  • 5. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia nervosa and obsessive-compulsive disorder in a prepubertal patient with bone dysplasia: a case report.
    Lázaro L; Moreno E; Baos P; Castro J
    Int J Eat Disord; 2005 Apr; 37(3):275-7. PubMed ID: 15822084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive and eating disorders: comparison of clinical and personality features.
    Jiménez-Murcia S; Fernández-Aranda F; Raich RM; Alonso P; Krug I; Jaurrieta N; Alvarez-Moya E; Labad J; Menchón JM; Vallejo J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):385-91. PubMed ID: 17610663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder.
    Moritz S; Fricke S; Jacobsen D; Kloss M; Wein C; Rufer M; Katenkamp B; Farhumand R; Hand I
    Behav Res Ther; 2004 Feb; 42(2):217-27. PubMed ID: 14975782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.
    Schulz SC
    Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
    Poyurovsky M
    Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anorexia nervosa and obsessive-compulsive disorder in a young Russian immigrant].
    Iancu I; Kikenzon L; Ratzoni G; Apter A
    Harefuah; 1993 Apr; 124(8):477-9, 527, 526. PubMed ID: 8335272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications.
    Poyurovsky M; Koran LM
    J Psychiatr Res; 2005 Jul; 39(4):399-408. PubMed ID: 15804390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant obsessive-compulsive disorder and schizotypal personality disorder.
    Jenike MA; Baer L; Minichiello WE; Schwartz CE; Carey RJ
    Am J Psychiatry; 1986 Apr; 143(4):530-2. PubMed ID: 3953896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
    Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic Considerations in the Treatment of an Adolescent with Anorexia Nervosa and Obsessive Compulsive Disorder.
    Rice T; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):444-7. PubMed ID: 26091198
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxetine efficacy in stuttering treatment.
    Boldrini M; Rossi M; Placidi GF
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):311-2. PubMed ID: 12975000
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistent obsessive-compulsive disorder and schizotypal personality disorder: a poor prognostic indicator.
    Jenike MA; Baer L; Minichiello WE; Schwartz CE; Carey RJ
    Arch Gen Psychiatry; 1986 Mar; 43(3):296. PubMed ID: 3954553
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Sevincok L; Uslu A; Kaynak H; Dereboy F
    J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders.
    Halmi KA; Tozzi F; Thornton LM; Crow S; Fichter MM; Kaplan AS; Keel P; Klump KL; Lilenfeld LR; Mitchell JE; Plotnicov KH; Pollice C; Rotondo A; Strober M; Woodside DB; Berrettini WH; Kaye WH; Bulik CM
    Int J Eat Disord; 2005 Dec; 38(4):371-4. PubMed ID: 16231356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.